Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biodesix Inc 919 WEST DILLON RD. LOUISVILLE CO 80027 USA

www.biodesix.com P: 303-417-0500 F: 866-432-3338

Description:

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 117,300
Enterprise Value, $K 126,300
Shares Outstanding, K 96,942
Annual Sales, $ 49,090 K
Annual Net Income, $ -52,150 K
Last Quarter Sales, $ 14,670 K
Last Quarter Net Income, $ -9,140 K
EBIT, $ -41,300 K
EBITDA, $ -30,640 K
60-Month Beta 1.13
% of Insider Shareholders 63.80%
% of Institutional Shareholders 20.96%
Float, K 35,093
% Float 36.20%
Short Volume Ratio 0.49

Growth:

1-Year Return -33.16%
3-Year Return -93.04%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 03/01/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -0.63
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year 64.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BDSX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -58.96%
Profit Margin % -106.23%
Debt/Equity 7.70
Price/Sales 2.47
Price/Cash Flow N/A
Price/Book 24.69
Book Value/Share 0.05
Interest Coverage -4.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar